These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35865680)

  • 1. Study on Conditional Conservatism Within Fair Value Measurements Based on Anti-discount Expectations.
    Yu Q; Guo J; Ding L; Hu Q
    Front Psychol; 2022; 13():923055. PubMed ID: 35865680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Corporate Capital Structure on Financial Performance Based on Convolutional Neural Network.
    Luo Y; Jiang C
    Comput Intell Neurosci; 2022; 2022():5895560. PubMed ID: 35515502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Chinese-style margin trading promote the high-quality development of listed companies?
    Tang J; Wu Y; Ye Y
    PLoS One; 2023; 18(4):e0284947. PubMed ID: 37104370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dataset of companies' profitability, government debt, financial statements' key indicators and earnings in an emerging market: Developing a panel and time series database of value-added tax rate increase impacts.
    Mgammal M; Al-Matari E
    F1000Res; 2023; 12():405. PubMed ID: 38434636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive pharmaceutical background, R&D investment and corporate innovation performance.
    Zhang L; Li S; Wu M
    Am J Transl Res; 2023; 15(11):6576-6586. PubMed ID: 38074834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constructing internal audit quality evaluation index: evidence from listed companies in Jiangsu province, China.
    Kai R; Yusheng K; Ntarmah AH; Ti C
    Heliyon; 2022 Sep; 8(9):e10598. PubMed ID: 36164523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Inhibitory Effect of the Deregulation Short-Sale on Private Equity Placement.
    Wang P; Su C; Xu B
    Front Psychol; 2022; 13():888805. PubMed ID: 35903744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESG performance, investor attention, and company reputation: Threshold model analysis based on panel data from listed companies in China.
    Meng T; Dato Haji Yahya MH; Ashhari ZM; Yu D
    Heliyon; 2023 Oct; 9(10):e20974. PubMed ID: 37876450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of companies disclosing ESG reports in multiple languages on the enthusiasm of foreign investors for holding shares.
    Bao R; Wei L
    PLoS One; 2024; 19(3):e0299643. PubMed ID: 38452011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of insurance institutional investors on corporate value from selection and creation perspective.
    Rong X; Zhang T; Liu K
    PLoS One; 2022; 17(7):e0269520. PubMed ID: 35776721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does CSR affect the cost of equity capital: Empirical evidence from the targeted poverty alleviation of listed companies in China.
    Yi Y; Xie B; Zhou L; Wei Y
    PLoS One; 2020; 15(2):e0227952. PubMed ID: 32032381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taking peers into account: Adoption and effects of high-investment human resource systems.
    Jiang K; Takeuchi R; Jia Y
    J Appl Psychol; 2021 Oct; 106(10):1539-1556. PubMed ID: 33017155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will R&D make investors more tolerant? Analysis based on the performance forecast of Chinese listed companies.
    Chen Y; Wang Y; Zhao H; Xu W
    PLoS One; 2023; 18(1):e0280237. PubMed ID: 36701361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial Management of Listed Companies Based on Convolutional Neural Network Model in the Context of Epidemic.
    Duan Q; Cao X; Xu L
    Comput Intell Neurosci; 2022; 2022():1871315. PubMed ID: 36164427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green credit policy and corporate excess cash holdings.
    Ning J; Wang G; Xiong F; Yin S
    PLoS One; 2024; 19(1):e0294079. PubMed ID: 38227573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of voluntary disclosure on financial performance: Empirical study on manufacturing industry in Indonesia.
    Meiryani ; Huang SM; Soepriyanto G; Jessica ; Fahlevi M; Grabowska S; Aljuaid M
    PLoS One; 2023; 18(6):e0285720. PubMed ID: 37267373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Industrial Investment Funds, Government R&D Subsidies, and Technological Innovation: Evidence From Chinese Companies.
    Ren YM
    Front Psychol; 2022; 13():890208. PubMed ID: 35774961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the R&D Expenditure of Listed Companies Green? Evidence from China's A-Share Market.
    Li B; Li L; Pi T
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterprise innovation and audit pricing: An evidence study from China's A-share listed companies.
    Zhang L; Su W; Liu S
    PLoS One; 2024; 19(3):e0300137. PubMed ID: 38466695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.